surfactin peptide has been researched along with Disease Models, Animal in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jeong, HJ; Jung, H; Kim, HM; Kim, HY | 1 |
| Ding, J; Liu, D; Qi, G; Xing, X; Zhao, X | 1 |
| Gao, Z; Mai, H; Qi, G; Shang, J; Shang, L; Yang, T; Zhao, X | 1 |
| Kavitha, P; Maheswari, P; Ramchand, CN; Ravichandran, M; Sas, B; Selvam, R | 1 |
| Fukuta, A; Kido, H; Kimoto, T; Mizuno, D; Shinahara, W; Takahashi, E; Takei, T; Yano, M | 1 |
5 other study(ies) available for surfactin peptide and Disease Models, Animal
| Article | Year |
|---|---|
Surfactin exerts an anti-cancer effect through inducing allergic reactions in melanoma skin cancer.
Topics: Amino Acid Sequence; Animals; Anti-Allergic Agents; Antineoplastic Agents; Apoptosis; Cell Degranulation; Cell Line, Tumor; Cell Proliferation; Cytokines; Disease Models, Animal; Histamine; Humans; Immunoglobulin E; Lipopeptides; Male; Mast Cells; Melanoma; Melanoma, Cutaneous Malignant; Mice, Inbred C57BL; Peptides, Cyclic; Skin Neoplasms | 2021 |
Enteric-coated insulin microparticles delivered by lipopeptides of iturin and surfactin.
Topics: Administration, Oral; Animals; Biological Availability; Blood Glucose; Diabetes Mellitus, Experimental; Disease Models, Animal; Humans; Hypoglycemic Agents; Insulin; Intestinal Mucosa; Lipopeptides; Mice, Inbred BALB C; Peptides, Cyclic | 2018 |
Immunomodulation therapy of diabetes by oral administration of a surfactin lipopeptide in NOD mice.
Topics: Administration, Oral; Animals; Diabetes Mellitus, Type 1; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Female; Flow Cytometry; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Incidence; Interleukin-10; Lipopeptides; Mice, Inbred NOD; Peptides, Cyclic; Survival Analysis; T-Lymphocyte Subsets; Treatment Outcome; Tumor Necrosis Factor-alpha | 2014 |
Effect of Bacillus subtilis PB6, a natural probiotic on colon mucosal inflammation and plasma cytokines levels in inflammatory bowel disease.
Topics: Animals; Bacillus subtilis; Bacterial Proteins; Body Weight; Colitis, Ulcerative; Colon; Cytokines; Disease Models, Animal; Intestinal Mucosa; Lipopeptides; Male; Organ Size; Peptides, Cyclic; Phospholipases A2; Probiotics; Random Allocation; Rats; Rats, Wistar; Trinitrobenzenesulfonic Acid | 2009 |
Surfactant protein C is an essential constituent for mucosal adjuvanticity of Surfacten, acting as an antigen delivery vehicle and inducing both local and systemic immunity.
Topics: Adjuvants, Immunologic; Administration, Intranasal; Animals; B7-2 Antigen; Biological Products; Disease Models, Animal; Female; Hemagglutinin Glycoproteins, Influenza Virus; Histocompatibility Antigens Class II; Immunity, Mucosal; Influenza Vaccines; Lipopeptides; Mice; Mice, Inbred BALB C; Orthomyxoviridae Infections; Peptides, Cyclic; Rodent Diseases; Vaccines, Subunit | 2011 |